Early in the coronavirus outbreak in Europe, Zentiva quickly adjusted its production plans to meet the needs of the public and healthcare workers in combatting the disease.

The company radically increased production of vital supplies for use in the fight against the coronavirus pandemic – and converted some manufacturing operations to produce a new sanitizer product.

In the Czech Republic, the company’s new branded sanitizer spray – “Anti-COVID” – is helping to check the spread of Covid-19. The product has an alcohol content of more than 80%, making it suitable for use on personal items and surfaces such as door handles, as well as for disinfecting hands.

To meet exceptionally high demand in local hospitals and pharmacies during the outbreak, Zentiva Romania has increased production of sodium metamizole, the primary active ingredient in the painkiller Algocalmin. Zentiva has succeeded in increasing production of sodium metamizole by up to 300%.

The company has already boosted its manufacturing of other analgesics such as paracetamol in response to the pandemic and is maintaining the production of drugs for other chronic illnesses.

Headquartered in Prague, Czech Republic, Zentiva produces high-quality, affordable medicines for patients in Europe and beyond. With more than 4,000 employees and a network of production sites – including flagship facilities in Prague and Bucharest, Romania – it is a leading producer of branded generic drugs and over-the-counter products